In the second part of this episode, the focus shifts from molecular mechanisms to real-world pathology. Hosts Dr. Camila Pupe and Dr. Wilson Marques Jr. welcome back:

  • Professor Anuraa Rambukkana – whose groundbreaking research on Schwann cell reprogramming has transformed our understanding of how Mycobacterium leprae targets and reshapes peripheral nerves.
  • Dr. Bruno Dornelas – Neuropathologist at the Federal University of Uberlândia, with extensive experience in leprosy pathology.

Discussion highlights include:

  • Histopathological patterns across the Ridley-Jopling spectrum (from tuberculoid to lepromatous forms)
  • How pathology findings correlate with bacterial mechanisms and immune response
  • Predictors of relapse and treatment failure (e.g., persistent lymphocytic infiltrates, foamy granulomas, bacillary index, and anti-PGL-1 serology)
  • Challenges in defining "cure" and monitoring patients post-MDT
  • The need for better diagnostic tools for early and atypical presentations
  • Future translational directions, including regenerative strategies inspired by bacterial-host interactions

This episode underscores the spectrum nature of leprosy neuropathy, the importance of long-term monitoring, and opportunities for innovation in therapy and diagnostics.

Transcript

Podden och tillhörande omslagsbild på den här sidan tillhör Peripheral Nerve Society (PNS). Innehållet i podden är skapat av Peripheral Nerve Society (PNS) och inte av, eller tillsammans med, Poddtoppen.